| Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer (NCT00501644) | M.D. Anderson Cancer Center | 2003-01-01 |
| Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer (NCT00155896) | National Taiwan University Hospital | 2003-01-01 |
| Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer (NCT00261027) | Ottawa Hospital Research Institute | 2003-01-01 |
| Depression Treatment and Screening in Ovarian Cancer Patients (NCT00515372) | M.D. Anderson Cancer Center | 2002-12-20 |
| Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer (NCT00058435) | Memorial Sloan Kettering Cancer Center | 2002-12-01 |
| Clinical Trial for Ovarian Cancer (OvaRex®) (NCT00050375) | Unither Pharmaceuticals | 2002-12-01 |
| Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer (NCT00061308) | GlaxoSmithKline | 2002-12-01 |
| Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants (NCT00228319) | Jeanne Drisko, MD, CNS, FACN | 2002-10-01 |
| Gefitinib in Treating Patients With Cervical Cancer (NCT00049556) | National Cancer Institute (NCI) | 2002-10-01 |
| Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk (NCT00017134) | Gynecologic Oncology Group | 2002-09-01 |
| A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood (NCT00117442) | Amgen | 2002-08-01 |
| S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer (NCT00043082) | SWOG Cancer Research Network | 2002-08-01 |
| Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer (NCT00052468) | AGO Study Group | 2002-08-01 |
| Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT00217555) | Fred Hutchinson Cancer Center | 2002-07-01 |
| PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer (NCT00085384) | M.D. Anderson Cancer Center | 2002-07-01 |
| A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer (NCT00277160) | Amgen | 2002-06-01 |
| UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer (NCT00045175) | University Health Network, Toronto | 2002-06-01 |
| Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy (NCT00084370) | University of Alabama at Birmingham | 2002-06-01 |
| Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor (NCT00039585) | National Cancer Institute (NCI) | 2002-05-01 |
| Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00055614) | Beth Israel Deaconess Medical Center | 2002-05-01 |
| Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer (NCT00039559) | Massachusetts General Hospital | 2002-05-01 |
| Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis (NCT00033605) | Alliance for Clinical Trials in Oncology | 2002-04-01 |
| Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients (NCT00082654) | Fred Hutchinson Cancer Center | 2002-03-01 |
| Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer (NCT00900289) | Liz-Anne Lewsley | 2002-03-01 |
| ABT-751 in Treating Young Patients With Refractory Solid Tumors (NCT00036959) | National Institutes of Health Clinical Center (CC) | 2002-03-01 |
| BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00346385) | ImmunoGen, Inc. | 2002-03-01 |
| Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer (NCT00034151) | Achieve Life Sciences | 2002-03-01 |
| Gleevec Study for Patients With Ovarian Cancer (NCT00510653) | M.D. Anderson Cancer Center | 2002-03-01 |
| Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane (NCT02728622) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2002-03-01 |
| Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer (NCT00511641) | M.D. Anderson Cancer Center | 2002-02-12 |
| Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00897806) | M.D. Anderson Cancer Center | 2002-02-01 |
| Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00030446) | NCIC Clinical Trials Group | 2002-01-10 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer (NCT00027534) | Michael Morse, MD | 2002-01-01 |
| Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation (NCT00036712) | Medical College of Wisconsin | 2002-01-01 |
| Mesothelin as a New Tumor Marker for Ovarian Cancer (NCT00155740) | National Taiwan University Hospital | 2002-01-01 |
| Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00028912) | Memorial Sloan Kettering Cancer Center | 2001-11-01 |
| Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy (NCT00030108) | National Institutes of Health Clinical Center (CC) | 2001-11-01 |
| Nonmyeloablative Allogeneic Transplant (NCT01272817) | Scripps Health | 2001-10-01 |
| Estrogen, Diet, Genetics and Endometrial Cancer (NCT00587886) | Memorial Sloan Kettering Cancer Center | 2001-09-25 |
| Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer (NCT00170573) | North Eastern German Society of Gynaecological Oncology | 2001-09-01 |
| Acupuncture to Improve Quality of Life in Patients With Advanced Cancer (NCT00070967) | National Center for Complementary and Integrative Health (NCCIH) | 2001-09-01 |
| Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (NCT00028743) | NCIC Clinical Trials Group | 2001-08-31 |
| Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer (NCT00032162) | AGO Study Group | 2001-08-01 |
| Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer (NCT01686256) | Endocyte | 2001-08-01 |
| Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples (NCT01034033) | Stanford University | 2001-08-01 |
| Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00023699) | Gynecologic Oncology Group | 2001-08-01 |
| Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer (NCT00031954) | AGO Study Group | 2001-08-01 |
| Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women (NCT00539162) | M.D. Anderson Cancer Center | 2001-07-02 |
| Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00023907) | Gynecologic Oncology Group | 2001-07-01 |
| Cancer Screening and Prevention Program for High Risk Women (NCT00849199) | NYU Langone Health | 2001-07-01 |
| A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer (NCT00587093) | Memorial Sloan Kettering Cancer Center | 2001-07-01 |
| Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer (NCT00020696) | Gynecologic Oncology Group | 2001-06-01 |
| S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer (NCT00023634) | SWOG Cancer Research Network | 2001-06-01 |
| Ovarian Screening Study (NCT00267072) | University of Louisville | 2001-06-01 |
| TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00022347) | Memorial Sloan Kettering Cancer Center | 2001-05-01 |
| Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer (NCT00021385) | Jonsson Comprehensive Cancer Center | 2001-05-01 |
| Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer (NCT00237627) | UNC Lineberger Comprehensive Cancer Center | 2001-05-01 |
| CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women (NCT00058032) | University College, London | 2001-04-17 |
| Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors (NCT00024258) | Memorial Sloan Kettering Cancer Center | 2001-03-01 |
| S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer (NCT00008138) | SWOG Cancer Research Network | 2001-03-01 |
| ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00014690) | AstraZeneca | 2001-03-01 |
| Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00021034) | Memorial Sloan Kettering Cancer Center | 2001-03-01 |
| Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer (NCT00006812) | Gynecologic Oncology Group | 2001-03-01 |
| CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer (NCT00017017) | Memorial Sloan Kettering Cancer Center | 2001-02-01 |
| Chemotherapy-Related Toxicities In Ovarian Cancer Patients (NCT00508378) | M.D. Anderson Cancer Center | 2001-01-01 |
| Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy (NCT00006028) | Gynecologic Oncology Group | 2001-01-01 |
| Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer (NCT00017303) | Cytran | 2001-01-01 |
| Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer (NCT00016224) | Memorial Sloan Kettering Cancer Center | 2001-01-01 |
| A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment (NCT00190697) | Eli Lilly and Company | 2001-01-01 |
| Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV (NCT00231075) | ARCAGY/ GINECO GROUP | 2001-01-01 |
| Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (NCT00550784) | City of Hope Medical Center | 2001-01-01 |
| Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma (NCT00157560) | Massachusetts General Hospital | 2000-12-01 |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer (NCT00006981) | National Cancer Institute (NCI) | 2000-12-01 |
| Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer (NCT00010179) | NCIC Clinical Trials Group | 2000-10-31 |
| Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum (NCT00012090) | Memorial Sloan Kettering Cancer Center | 2000-09-01 |
| Screening Women at High Genetic Risk for Ovarian Cancer (NCT00033488) | University College London Hospitals | 2000-09-01 |
| Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer (NCT00006099) | Ludwig Institute for Cancer Research | 2000-08-02 |
| SU5416 and Carboplatin to Treat Ovarian Cancer (NCT00006155) | National Cancer Institute (NCI) | 2000-08-01 |
| Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (NCT00004157) | Fred Hutchinson Cancer Center | 2000-08-01 |
| STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma (NCT00006357) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-08-01 |
| Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer (NCT00006356) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-08-01 |
| Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00006391) | NYU Langone Health | 2000-08-01 |
| Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients (NCT01689636) | Endocyte | 2000-08-01 |
| Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors (NCT00005952) | Duke University | 2000-08-01 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283) | Fred Hutchinson Cancer Center | 2000-07-01 |
| Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer (NCT00005807) | Albert Einstein College of Medicine | 2000-07-01 |
| Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer (NCT00006262) | Northwestern University | 2000-07-01 |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (NCT00900094) | University of Michigan Rogel Cancer Center | 2000-06-01 |
| Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer (NCT00005025) | John Stoddard Cancer Center at Iowa Methodist Medical Center | 2000-06-01 |
| Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors (NCT00020150) | National Cancer Institute (NCI) | 2000-06-01 |
| Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer (NCT00045461) | Ludwig-Maximilians - University of Munich | 2000-06-01 |
| Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer (NCT00019916) | National Cancer Institute (NCI) | 2000-06-01 |
| Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer (NCT00006230) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-05-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer (NCT00005858) | University of Maryland, Baltimore | 2000-04-01 |
| Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors (NCT00003811) | Children's Oncology Group | 2000-04-01 |
| Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer (NCT00005046) | Gynecologic Oncology Group | 2000-04-01 |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00006036) | NCIC Clinical Trials Group | 2000-03-22 |
| Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer (NCT00017537) | University of Alabama at Birmingham | 2000-03-01 |
| Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients (NCT00579514) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Specimen and Data Study for Ovarian Cancer Early Detection and Prevention (NCT00005095) | Northwestern University | 2000-03-01 |